A 66 Patient Multi-Institution Phase IV Post-Authorization Surveillance of ProThelial ™ (High Potency Polymerized Cross-linked Sucralfate) Single Agent Efficacy for the Prevention and Rapid Reversal of Chemo-radiation (Peer reviewer for this article)

Citation:
McCullough, R. W., "A 66 Patient Multi-Institution Phase IV Post-Authorization Surveillance of ProThelial ™ (High Potency Polymerized Cross-linked Sucralfate) Single Agent Efficacy for the Prevention and Rapid Reversal of Chemo-radiation (Peer reviewer for this article)", British Journal of Medicine and Medical Research, vol. 10, issue 2, pp. 1-17, 2015.